Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy. | Front Neurol | 2023 | 38178892 | PubTator, text mining | PubMed |
| A Rare Case of Non-Neurological Ptosis. | Cureus | 2023 | 38161878 | PubTator, text mining | PubMed |
| Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine. | Arq Neuropsiquiatr | 2023 | 38157878 | PubTator, text mining | PubMed |
| Electrophysiological evaluation of the neuromuscular junction: a brief review. | Arq Neuropsiquiatr | 2023 | 38157872 | PubTator, text mining | PubMed |
| Assessing the length of hospital stay for patients with myasthenia gravis based on the data mining MARS approach. | Front Neurol | 2023 | 38156090 | PubTator, text mining | PubMed |
| The genetic puzzle of a SOD1-patient with ocular ptosis and a motor neuron disease: a case report. | Front Genet | 2023 | 38152653 | PubTator, text mining | PubMed |
| Guideline for the management of myasthenic syndromes. | Ther Adv Neurol Disord | 2023 | 38152089 | PubTator, text mining | PubMed |
| Therapeutic effect of ofatumumab in patients with myasthenia gravis: immunoregulation of follicular T helper cells and T helper type 17 cells. | Front Neurol | 2023 | 38146439 | PubTator, text mining | PubMed |
| Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis. | Vaccines (Basel) | 2023 | 38140161 | PubTator, text mining | PubMed |
| Plasma Exchange versus Intravenous Immunoglobulin in Worsening Myasthenia Gravis: A Systematic Review and Meta-Analysis with Special Attention to Faster Relapse Control. | Biomedicines | 2023 | 38137401 | PubTator, text mining | PubMed |
| Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background. | Pathophysiology | 2023 | 38133144 | PubTator, text mining | PubMed |
| Correlation between Cardiovascular Autonomic and Pulmonary Ventilation Functions in Myasthenia Gravis Patients. | Adv Respir Med | 2023 | 38131875 | PubTator, text mining | PubMed |
| Case Report: Extraocular muscles paralysis associated with GAD65 antibody: a case series study. | Front Immunol | 2023 | 38106406 | PubTator, text mining | PubMed |
| An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis. | Expert Opin Biol Ther | 2023 | 38099334 | PubTator, text mining | PubMed |
| Spontaneously resolving late-onset ocular myasthenia related to COVID-19. A case report. | Acta Myol | 2023 | 38090545 | PubTator, text mining | PubMed |
| A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis. | J Inflamm Res | 2023 | 38088944 | PubTator, text mining | PubMed |
| Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients. | BMC Neurol | 2023 | 38082244 | PubTator, text mining | PubMed |
| Editorial: Phenotypes of myasthenia gravis, volume II. | Front Neurol | 2023 | 38073651 | PubTator, text mining | PubMed |
| Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy. | Cancers (Basel) | 2023 | 38067278 | PubTator, text mining | PubMed |
| Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence. | Neuropsychiatr Dis Treat | 2023 | 38059203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=17